Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2020 11:51 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation

CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its increased commitment to the global fight against COVID-19 by making available zero cost...
March 16, 2020 08:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces FDA-Clearance for New Curian™ Analyzer and the Curian™ HpSA® Assay

CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of immunoassay, molecular, and blood chemistry diagnostic testing solutions, today announced that...
February 26, 2020 08:00 ET | Source: Meridian Bioscience Inc.

Meridian’s Novel Air-Dryable qPCR Mix Decreases Costs and Simplifies Workflows for Molecular Test Manufacturers

CINCINNATI, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), following the extremely successful launch of the Lyo-Ready qPCR mixes, is proud to introduce today its...
February 19, 2020 09:15 ET | Source: Meridian Bioscience Inc.; Exalenz Bioscience

Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform

CINCINNATI and MODIIN, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies have entered...
February 07, 2020 07:30 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance

CINCINNATI, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2019. First Quarter Fiscal 2020...
January 27, 2020 09:17 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak

CINCINNATI, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced a novel coronavirus, identified by Chinese authorities on January 7 and currently named...
January 23, 2020 16:46 ET | Source: Meridian Bioscience Inc.

メリディアン、NGSおよびPCRアプリケーション向けの確実な増幅を実現する新しいハイフィデリティ･ポリメラーゼを公開

シンシナティ発, Jan. 24, 2020 (GLOBE NEWSWIRE) -- メリディアン･バイオサイエンス (Meridian Bioscience, Inc.、NASDAQ: VIVO) は本日、High-Specificity Pfu HS Mixを発表した。これはハイフィデリティ増幅を実現するだけでなく、コンパニオン診断 (CDx)...
January 23, 2020 16:46 ET | Source: Meridian Bioscience Inc.

Meridian Meluncurkan Polimerase Fidelitas Tinggi Baru dengan Kemampuan Amplifikasi Canggih bagi Aplikasi NGS dan PCR

CINCINNATI, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) hari ini mengumumkan peluncuran High-Specificity Pfu HS Mix yang menyediakan amplifikasi fidelitas tinggi,...
January 23, 2020 16:46 ET | Source: Meridian Bioscience Inc.

Meridian bietet mit neuer High-Fidelity-Polymerase stabile Amplifikation für NGS- und PCR-Anwendungen

CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) hat heute die Einführung eines High-Specificity Pfu HS Mix bekanntgegeben, der neben einer...
January 23, 2020 16:46 ET | Source: Meridian Bioscience Inc.

Meridian lance une nouvelle polymérase haute-fidélité pour fournir une amplification robuste aux applications NGS et PCR

CINCINNATI, 23 janv. 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ : VIVO) a annoncé aujourd'hui le lancement d'un mélange Pfu HS de haute spécificité qui non seulement fournit une...